X4 Pharmaceuticals (XFOR) EPS (Basic) Growth (5y) (2022 - 2026)
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) EPS (Basic) Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | X4 Pharmaceuticals | 510.43 Mn | 315.33 Mn | 7.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.61% |
| Mar 31, 2026 | 34.17% |
| Dec 31, 2025 | 9.21% |
| Sep 30, 2025 | 4.54% |
| Jun 30, 2025 | -35.66% |
| Mar 31, 2025 | 15.69% |
| Dec 31, 2024 | -44.60% |
| Sep 30, 2024 | -35.10% |
| Jun 30, 2024 | 19.59% |
| Mar 31, 2024 | 47.79% |
| Dec 31, 2023 | 53.68% |
| Sep 30, 2023 | 68.74% |
| Jun 30, 2023 | 35.04% |
| Mar 31, 2023 | 45.44% |
| Dec 31, 2022 | 41.35% |
| Sep 30, 2022 | 71.33% |
| Jun 30, 2022 | 61.05% |
| Mar 31, 2022 | 59.13% |